BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15087241)

  • 21. Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex.
    Muraki I; Inoue T; Hashimoto S; Izumi T; Ito K; Koyama T
    J Neurochem; 2001 Jan; 76(2):490-7. PubMed ID: 11208912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of imipramine on extracellular serotonin and noradrenaline concentrations in ACTH-treated rats.
    Kitamura Y; Akiyama K; Hashimoto S; Kitagawa K; Kawasaki H; Shibata K; Shinomiya K; Suemaru K; Araki H; Sendo T; Gomita Y
    Eur J Pharmacol; 2007 Jul; 566(1-3):113-6. PubMed ID: 17459373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
    Swanson CJ; Perry KW; Koch-Krueger S; Katner J; Svensson KA; Bymaster FP
    Neuropharmacology; 2006 May; 50(6):755-60. PubMed ID: 16427661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
    Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
    Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
    Johansson D; Falk A; Marcus MM; Svensson TH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain.
    Yamauchi M; Imanishi T; Koyama T
    Neuropharmacology; 2012 Jun; 62(7):2278-87. PubMed ID: 22342987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
    Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
    Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved preclinical cardiovascular therapeutic indices with long-term inhibition of norepinephrine reuptake using reboxetine.
    Fossa AA; Wisialowski TA; Cremers T; van der Hart M; Tseng E; Deng S; Rollema H; Wang EQ
    Toxicol Appl Pharmacol; 2012 Nov; 264(3):343-50. PubMed ID: 23000177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex.
    Yoshitake T; Yoshitake S; Fujino K; Nohta H; Yamaguchi M; Kehr J
    J Neurosci Methods; 2004 Dec; 140(1-2):163-8. PubMed ID: 15589346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
    Hernández LF; Segovia G; Mora F
    Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic treatment with antidepressant drugs reversibly alters NMDA mediated regulation of extracellular 5-HT in rat frontal cortex.
    Owen JC; Whitton PS
    Brain Res Bull; 2006 Jun; 70(1):62-7. PubMed ID: 16750484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex.
    Carboni E; Silvagni A; Vacca C; Di Chiara G
    J Neurochem; 2006 Jan; 96(2):473-81. PubMed ID: 16336224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
    Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
    J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
    Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
    Pan WH; Yang SY; Lin SK
    Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex.
    Devoto P; Flore G; Saba P; Fà M; Gessa GL
    J Neurochem; 2005 Jan; 92(2):368-74. PubMed ID: 15663484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
    Iskra-Jopa J; Gołembiowska K; Dziubina A; Cybulski M; Duszyńska B; Chilmonczyk Z
    J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep--wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats.
    Léna I; Parrot S; Deschaux O; Muffat-Joly S; Sauvinet V; Renaud B; Suaud-Chagny MF; Gottesmann C
    J Neurosci Res; 2005 Sep; 81(6):891-9. PubMed ID: 16041801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex.
    Pira L; Mongeau R; Pani L
    Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.